Patents Assigned to Stichting Klinische Farmacologie Groningen
  • Use of erythropoietin for the preventive or curative treatment of cardiac failure
    Patent number: 7335490
    Abstract: Provided are uses of erythropoietin, or a derivative or functional analogue thereof, for the production of a medicament for the preventive or curative treatment of patients suffering from, or at risk of suffering from, cardiac failure.
    Type: Grant
    Filed: January 9, 2003
    Date of Patent: February 26, 2008
    Assignees: Crucell Holland B.V., Stichting Klinische Farmacologie Groningen
    Inventors: Wiekert Hendrikus Van Gilst, Ronald Hendrik Peter Brus, Dirk Jan Van Veldhuisen, Robert Henk Henning, Rudolf Allert De Boer